Portola Pharmaceuticals is Pharmaceuticals in United States that focus on Portola Pharmaceuticals Inc business. Founded in 2003. They cover business area such as Portola Pharmaceuticals Inc, novel therapeutic, area, thrombosis, inflammation, patient, biomarker or genetic approach, clinical development, clinical, regulatory, and commercial success, class, collaborative agreement.
2003
( 21 years old in 2024 )
Portola Pharmaceuticals Inc
-
270 East Grand Avenue
South San Francisco, CA 94080
United States
Private
Portola Pharmaceuticals Incnovel therapeuticareathrombosisinflammationpatientbiomarker or genetic approachclinical developmentclinical, regulatory, and commercial successclasscollaborative agreement
* We use standard office opening hours in near Portola Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Portola Pharmaceuticals is Pharmaceuticals business from United States that founded in 2003 (21 years old in 2024), Portola Pharmaceuticals business is focusing on Portola Pharmaceuticals Inc.
Portola Pharmaceuticals headquarter office and corporate office address is located in 270 East Grand Avenue South San Francisco, CA 94080 United States.
Portola Pharmaceuticals was founded in United States.
In 2024, Portola Pharmaceuticals is currently focus on Portola Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Portola Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Portola Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
